Romualdo Barroso, MD PhD
@DrRBarroso
Followers
2K
Following
5K
Statuses
2K
Medical Oncologist and National Leader of Breast Oncology at DASA Oncology #brasilia #Breastcancer #Immunotherapy #clinicalresearch #dasa #dasaoncology
Brasília, Brasil
Joined December 2015
Congrat Sara! Well deserved @stolaney1
Congratulations to Dr. Sara Tolaney (@stolaney1) on earning the Fellows of ASCO (FASCO) distinction!
0
0
5
RT @PabloMando: 📣Jovenes oncologos de LATAM a no perderse el preceptorship de @myESMO que se llevará a cabo el 9 y 10 de abril 📆 antes del…
0
14
0
RT @hoperugo: Wow. I am so grateful for our BC community for supporting our good friend and colleague @dradityabardia and his family duri…
0
17
0
Emocionante!
Homenagem especial: Fernanda Montenegro escreve carta para a filha, Fernanda Torres, que ganhou o prêmio de Melhor Atriz no Globo de Ouro. “Fato difícil de se alcançar, eu sei na pele... Bravo, minha filha, bravo.” ➡ Assista ao #GloboNewsMais na #GloboNews:
0
0
3
RT @renata_bonadio: #SABCS24 📍Dose-dense AC associated with higher RCB 0-1 rate compared to q3w AC during neoadjuvant CT+pembro for TNBC 📍N…
0
41
0
RT @DFCI_BreastOnc: #SABCS24 POSTER SESSION | P3-09-19 | Tumor genomics in young patients with #MetastaticBreastCancer. #KristenBrantley @D…
0
2
0
@infraero @mporoficial serviço de bagagem no aeroporto de Fortaleza administrado pela Fraport deixando a desejar…mais de 30min após a aeronave aterrizar e estacionar e nada… responsabilidade de quem? Fraport? @VoeGOLoficial Experiência do usuário ruim
1
0
0
RT @LauraTe96206949: O GBECAM completará 20 anos em 2025, fruto da iniciativa de três brilhantes oncologistas: José Bines, Carlos Barrios e…
0
4
0
Thank you Dr @RitaNandaMD for your kindness and for sharing so much knowledge with us in the Annual Meeting of the Brazilian Society of Clinical Oncology @SBOC_Oncologia
0
0
11
Dr @jhaveri_komal lecturing on the future of ER+ MBC in the Brazilian Society of Clinical Oncology- thank you for all your work on the field @SBOC_Oncologia
0
1
17
RT @OncoAlert: Neoadjuvant Immunotherapy—From Trials to Practice out on @JAMAOnc by @EMittendorfMD and our @oncoAlert #BreastCancer Faculty…
0
27
0
RT @oncodaily: ddAC vs q3wAC regimen in patients with TNBC treated with pembrolizumab plus CT in the neoadjuvant setting - @DrRBarroso
@TN…
0
3
0
@drjeanpereira @renata_bonadio @assad_daniele @DGagliato Obrigado. Depois desse trabalho eu fiquei mais inclinado a fazer dose-densa, principaLmente em pacientes com estadio III
0
0
2
While no significant disparities in drug discontinuation was noted, ddAC showed a trend towards higher rates of grade ≥3 AE (40.5% vs. 30.7%, P = 0.092). We hope to present survival outcomes in the future.
0
1
7